EANS-DD: AGENNIX AG
Notification concerning transactions by persons performing
managerial responsibilities pursuant to section 15a of the WpHG
--------------------------------------------------------------------------------
Notification concerning transactions by persons discharging managerial
responsibilities pursuant to section 15a of the WpHG, transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement:
--------------------------------------------------------------------------------
Person, triggering the disclosure:
-----------------------------
Name: dievini Hopp BioTech holding GmbH & Co. KG
(Legal person, company or institution)
Reason for the disclosure requirement:
------------------------------
Reason: Legal person, company or institution closely associated
Relationship: To a person performing managerial responsibilities
Person performing managerial responsibilities, triggering the disclosure
requirement:
--------------------------------------------------------------------------------
Position: Member of an administrative or supervisory body
Details of the transaction:
--------------------------------------------------------------------------------
Transaction:
------------
Description of financial instrument: Ordinary Bearer Shares (no-par value)
ISIN: DE000A1A6XX4
Type of transaction: Oversubscription
Date: 06.12.2011
Currency: Euro
Price: 2.95000
No of items: 3115520
Total amount traded: 9,190,784.00000
Place: OTC
Explanation: The subscription of the new shares by dievini Hopp BioTech
holding GmbH & Co. KG by corresponding oversubscription
order in the ongoing capital increase utilizing authorized
capital is attributed to both of the named board members.
Further inquiry note:
-----------------
Barbara Mueller
Manager, Investor Relations & Corporate Communications
Phone: +49 (0)89 8565 2693
ir@agennix.com
In the U.S.: Laurie Doyle
Senior Director, Investor Relations & Corporate Communications
Phone: +1 609 524 5884
laurie.doyle@agennix.com
Issuer subject to the publication requirement:
--------------------------------------------------------------------------------
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: AGENNIX AG
Im Neuenheimer Feld 515
D-69120 Heidelberg
phone: +49 89 8565 2693
FAX: +49 89 8565 2610
mail: ir@agennix.com
WWW: http://www.agennix.com
sector: Pharmaceuticals
ISIN: DE000A1A6XX4
indexes: CDAX, Prime All Share, Technology All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Hamburg, Düsseldorf, Hannover, München
language: English
Original content of: AGENNIX AG i.L., transmitted by news aktuell